BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16103013)

  • 1. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Cimino F; Martino M; Minciullo PL; Calabrò C; Saija A; Gangemi S
    Transfus Apher Sci; 2005 Oct; 33(2):141-6. PubMed ID: 16103013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
    J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.
    Martino M; Morabito F; Callea I; Pontari A; Irrera G; Pucci G; Dattola A; Messina G; Console G; Iacopino P
    Transfus Med; 2005 Aug; 15(4):323-8. PubMed ID: 16101811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
    Cella G; Marchetti M; Vignoli A; Randi ML; Saggiorato G; Pasetto L; Pagnan A; Barbui T; Falanga A
    Leukemia; 2006 Aug; 20(8):1430-4. PubMed ID: 16775616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization.
    Sohn SK; Kim JG; Sung WJ; Kim DH; Suh JS; Lee KS; Lee KB
    J Clin Apher; 2003; 18(4):186-9. PubMed ID: 14699595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.
    Marmier-Savet C; Larosa F; Legrand F; Witz B; Michallet M; Ranta D; Louvat P; Puyraveau M; Raus N; Tavernier M; Mathieu-Nafissi S; Hequet O; Pouthier F; Deconinck E; Tiberghien P; Robinet E
    Transfusion; 2010 Dec; 50(12):2676-85. PubMed ID: 20663114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
    Ripa RS; Wang Y; Jørgensen E; Johnsen HE; Hesse B; Kastrup J
    Eur Heart J; 2006 Aug; 27(15):1785-92. PubMed ID: 16825290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
    Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
    Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
    Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H
    Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.